Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Targeting the endocannabinoid system might help reduce hair pulling in trichotillomania.

Apremilast shows promise for several skin conditions but needs more research.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Epithelial stem cells are crucial for tissue renewal and repair, and understanding them could improve treatments for damage and cancer.

Canine hair follicles have stem cells similar to human hair follicles, useful for studying hair disorders.

Bicalutamide may help treat female pattern hair loss.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Scientists found ways to identify and collect skin stem cells, which vary by skin area and are delicate.

Finasteride reduces gambling symptoms in Parkinson's patients.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The β-sitosterol hair gel is effective and promising for treating hair loss.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

A portable imaging system shows promise for diagnosing skin diseases and checking laser treatment effects.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.